News

BIDIPHAR HONORED TO WELCOME DELEGATION FROM HO CHI MINH CITY UNIVERSITY OF MEDICINE AND PHARMACY AT ITS ONCOLOGY DRUG MANUFACTURING FACILITY

14/03/2025

On March 14, 2025, Bidiphar, the Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company, had the privilege of hosting a delegation from the Ho Chi Minh City University of Medicine and Pharmacy at its state-of-the-art oncology drug manufacturing facility, the largest of its kind in Vietnam, located in the Nhon Hoi Economic Zone. This event marked a significant milestone in the collaborative relationship between Bidiphar and one of the nation’s leading medical and pharmaceutical training institutions, opening new prospects for research, education, and healthcare workforce development.

BIDIPHAR VINH DỰ ĐÓN TIẾP ĐOÀN TRƯỜNG ĐẠI HỌC Y DƯỢC TP.HCM TẠI NHÀ MÁY SẢN XUẤT THUỐC ĐIỀU TRỊ UNG THƯ

A Warm and Meaningful Meeting

BIDIPHAR VINH DỰ ĐÓN TIẾP ĐOÀN TRƯỜNG ĐẠI HỌC Y DƯỢC TP.HCM TẠI NHÀ MÁY SẢN XUẤT THUỐC ĐIỀU TRỊ UNG THƯ

The delegation was led by Associate Professor Dr. Ngô Quốc Đạt, Rector of the Ho Chi Minh City University of Medicine and Pharmacy, and included Professor Dr. Trần Thành Đạo, Dean of the Faculty of Pharmacy, along with distinguished lecturers and experts. The meeting took place in a warm yet highly professional atmosphere, reflecting mutual respect and a shared desire for long-term collaboration.

Representing Bidiphar, People’s Physician and General Director Phạm Thị Thanh Hương warmly welcomed the delegation and shared highlights of the company’s achievements in the pharmaceutical sector. She emphasized: “Bidiphar is proud to be a leading pharmaceutical science and technology enterprise, where many alumni of the Ho Chi Minh City University of Medicine and Pharmacy hold key positions. The high-quality training provided by the university has significantly contributed to our exceptional workforce. Bidiphar is committed to partnering with the university in education, research, and socially responsible initiatives.”

Factory Tour: A Testament to Advanced Technology

BIDIPHAR VINH DỰ ĐÓN TIẾP ĐOÀN TRƯỜNG ĐẠI HỌC Y DƯỢC TP.HCM TẠI NHÀ MÁY SẢN XUẤT THUỐC ĐIỀU TRỊ UNG THƯ

A key highlight of the visit was a tour of Bidiphar’s modern oncology drug manufacturing facility. The delegation gained firsthand insight into the internationally compliant production processes, from research and development to quality control. As Vietnam’s largest facility for oncology drugs, the factory symbolizes Bidiphar’s substantial investment in science and technology.

BIDIPHAR VINH DỰ ĐÓN TIẾP ĐOÀN TRƯỜNG ĐẠI HỌC Y DƯỢC TP.HCM TẠI NHÀ MÁY SẢN XUẤT THUỐC ĐIỀU TRỊ UNG THƯ

Members of the delegation expressed their admiration for the advanced infrastructure, automated production lines, and rigorous quality control processes. The technological solutions implemented ensure product efficacy and demonstrate Bidiphar’s commitment to delivering high-quality medications, significantly enhancing treatment outcomes for cancer patients in Vietnam.

BIDIPHAR VINH DỰ ĐÓN TIẾP ĐOÀN TRƯỜNG ĐẠI HỌC Y DƯỢC TP.HCM TẠI NHÀ MÁY SẢN XUẤT THUỐC ĐIỀU TRỊ UNG THƯ

BIDIPHAR VINH DỰ ĐÓN TIẾP ĐOÀN TRƯỜNG ĐẠI HỌC Y DƯỢC TP.HCM TẠI NHÀ MÁY SẢN XUẤT THUỐC ĐIỀU TRỊ UNG THƯ

Proposals for Collaboration: Looking to the Future

BIDIPHAR VINH DỰ ĐÓN TIẾP ĐOÀN TRƯỜNG ĐẠI HỌC Y DƯỢC TP.HCM TẠI NHÀ MÁY SẢN XUẤT THUỐC ĐIỀU TRỊ UNG THƯ

During the discussions, Associate Professor Dr. Ngô Quốc Đạt expressed gratitude to Bidiphar for its longstanding support for the university’s students and programs. He highlighted the importance of bridging academic institutions and businesses to elevate the quality of medical and pharmaceutical education. He proposed deepening collaboration in areas such as scientific research, development of new pharmaceutical products, and training of high-quality human resources.

These proposals were met with strong agreement from Bidiphar. General Director Phạm Thị Thanh Hương affirmed the company’s readiness to support internship programs, research initiatives, and corporate social responsibility (CSR) projects focused on education. The synergy between the university’s training expertise and Bidiphar’s practical experience promises to drive significant advancements, not only in pharmaceuticals but also in improving community healthcare.

A Shared Vision: Building a Sustainable Healthcare Ecosystem

This event was more than a meeting—it laid the foundation for a robust partnership between Bidiphar and the Ho Chi Minh City University of Medicine and Pharmacy. Both parties share a common vision of developing a sustainable healthcare ecosystem where technology, education, and social responsibility converge to maximize benefits for the community.

BIDIPHAR VINH DỰ ĐÓN TIẾP ĐOÀN TRƯỜNG ĐẠI HỌC Y DƯỢC TP.HCM TẠI NHÀ MÁY SẢN XUẤT THUỐC ĐIỀU TRỊ UNG THƯ

The meeting concluded with optimism and strong commitments from both sides. It sets the stage for future collaborative projects, ranging from pharmaceutical research and workforce training to CSR initiatives, all aimed at enhancing the quality of life for the people of Vietnam.

Facebook

View More